Quest Diagnostics Incorporated
DGX
$175.40
$1.640.94%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.40% | 15.63% | 0.44% | -2.55% | -3.96% |
| Total Depreciation and Amortization | 20.69% | 23.85% | 12.61% | 4.46% | 8.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.67% | 42.31% | 147.37% | 25.00% | -18.92% |
| Change in Net Operating Assets | 51.61% | -81.03% | 71.62% | -107.41% | 26.19% |
| Cash from Operations | 103.90% | -11.95% | 71.98% | -18.92% | 63.83% |
| Capital Expenditure | -12.50% | -70.83% | -0.95% | 11.54% | 18.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -76,550.00% | 81.66% | -358.06% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.94% | 109.52% | -- | -- | -- |
| Cash from Investing | 46.01% | -340.35% | -1,426.17% | 70.67% | -34.81% |
| Total Debt Issued | -- | -100.00% | 232.01% | -- | -- |
| Total Debt Repaid | -- | 99.76% | 99.83% | 56.25% | -- |
| Issuance of Common Stock | 141.67% | 75.00% | 84.62% | -27.27% | -52.00% |
| Repurchase of Common Stock | -82.61% | 45.09% | -- | -- | 17.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.33% | -5.00% | -5.00% | -5.00% | -6.76% |
| Other Financing Activities | -25.40% | 2,150.00% | -153.85% | 108.33% | -6,400.00% |
| Cash from Financing | -266.67% | -230.77% | 2,232.53% | -292.06% | -101.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.28% | -139.59% | 2,800.00% | -314.29% | -51.43% |